Dr. Gregory G. Ginsberg, MD

Dr. Ginsberg practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Ginsberg's NPI, 1548274244, was assigned on July 28, 2006. Dr. Ginsberg graduated from Jefferson Medical College of Thomas Jefferson University in 1987. Dr. Ginsberg holds Pennsylvania license MD044766E.

Dr. Ginsberg's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Ginsberg's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Ginsberg is also affiliated with Chester County Hospital. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Ginsberg to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ginsberg practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Ginsberg's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Ginsberg is licensed in Pennsylvania.

CMS data shows 558 Medicare services from Dr. Ginsberg across 18 procedure codes in 2024, for 415 Medicare patients. Medicare paid $80,505 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 415 Medicare patients who saw Dr. Ginsberg in 2024. The largest group is 65 to 74, with 218 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ginsberg's median patient age at 68, with 46% women.

In 2024, Dr. Ginsberg wrote 308 Medicare Part D claims for 74 patients. 91% of them were for generic drugs. CMS names the drug for 235 of them, across 4 drugs with 11 or more claims each, at $8,901 in total drug cost. In 2023, CMS named 145 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Ginsberg for performance year 2024, reported as part of a group. Dr. Ginsberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 425 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Ginsberg, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 48 papers to Dr. Ginsberg, published from 2017 to 2025. 2020 was the busiest year, with 8. The most frequent topics are Esophageal Neoplasms, Adenocarcinoma and Barrett Esophagus. Dr. Ginsberg has published most often in Gastrointest Endosc. Dr. Ginsberg's most frequent co-authors are Gary W. Falk, MD, Michael Lee Kochman, MD and Anil K. Rustgi, MD.

CMS Open Payments shows 290 general payments to Dr. Ginsberg from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 74% of the total. Olympus Corporation paid the most, $252,788. It also lists 3 research payments totaling $106,892 from 2017 to 2023.

Dr. Ginsberg graduated from Jefferson Medical College of Thomas Jefferson University in 1987.